News Release 

Examining risk of suicide and use of ACE inhibitors, ARBs

JAMA Network Open

What The Study Did: Associations between risk of suicide and medications widely used in the management of high blood pressure, chronic kidney disease, heart failure and diabetes (angiotensin-converting enzyme inhibitors and angiotensin receptor blockers) were examined in this observational study.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

Authors: Tony Antoniou, Pharm.D., Ph.D., of St. Michael's Hospital in Toronto, is the corresponding author.

(doi:10.1001/jamanetworkopen.2019.13304)

Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

###

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time: http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2019.13304?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=101619

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. Every Wednesday and Friday, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.